News

Member Portal

Stelara Now Indicated for Psoriatic Arthritis in Children

August 1, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in August

July 31, 2022

Rebinyn Approved to Prevent Hemophilia B Bleeding Episodes

July 29, 2022

New Topical Medication Zoryve Approved for Plaque Psoriasis

July 29, 2022

Benlysta Approved for Younger Lupus Nephritis Patients

July 26, 2022

FDA Approves First Therapy for Repigmentation in Vitiligo

July 19, 2022

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

By submitting this form, you are consenting to receive marketing emails from: Benecard Services, LLC. (Lawrenceville, NJ 08648), https://www.benecard.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.

News

Stelara Now Indicated for Psoriatic Arthritis in Children

Enhertu

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Rebinyn Approved to Prevent Hemophilia B Bleeding Episodes

New Topical Medication Zoryve Approved for Plaque Psoriasis

Benlysta Approved for Younger Lupus Nephritis Patients

Hadlima

FDA Approves First Therapy for Repigmentation in Vitiligo

Lumryz

Benefit Advisors & Employees - Want to know more?

Benecard

Newsletter